RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma
RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma
Recruiting · NCT07445022 · Registry updated 2026-03-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma | Melanoma Advanced | Recruiting | Phase 4 | 2026-03-03 | NCT07445022 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University Shanghai Cancer Center | Shanghai | China | 128 |